Journal
RESEARCH IN VETERINARY SCIENCE
Volume 135, Issue -, Pages 412-415Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.rvsc.2020.10.025
Keywords
Autophagy; Canine squamous cell carcinoma; Cell death; Survivin; YM155
Categories
Funding
- Japan Society for the Promotion of Science [19H03131]
- Grants-in-Aid for Scientific Research [19H03131] Funding Source: KAKEN
Ask authors/readers for more resources
The study found that the survivin inhibitor YM155 can inhibit the growth of canine squamous cell carcinoma cells by activating autophagy, leading to cell death.
Canine squamous cell carcinoma (SCC) is difficult to treat if local therapy is not feasible. Recently, survivin inhibitor YM155 was shown to have growth inhibitory activity on high-survivin-expressing canine SCC cell lines HAPPY and SQ4. Here, the mechanisms underlying the effect of YM155 on these cell lines were investigated. YM155 induced cleavage of poly(ADP-ribose) polymerase (PARP) in HAPPY, but not in SQ4 cells. Analyzing two autophagy markers, the level of microtubule-associated protein 1 light chain 3 (LC3)-II and the LC3-II/LC3-I ratio, indicated that YM155 activates autophagy in both cell lines, and this activation occurs prior to PARP cleavage in HAPPY cells. Moreover, inhibition of autophagic flux by chloroquine almost completely prevented the toxic effect of YM155 in both cell lines. Although there are differences in their eventual cell death type, both cell lines may be committed to cell death by activation of autophagy with YM155. Activation of autophagy is likely to be a key mechanism in the growth-inhibitory effects of YM155 in these lines. These data provide new insights into the cytotoxic mechanism of YM155 in canine SCC cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available